A COMPARISON OF THE EFFECTIVENESS OF DIFFERENT TREATMENT REGIMENS WITH THE USE OF ABIRATERONE ACETATE AND DOCETAXEL IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER

作者
A.V. Kondrashina,Л. М. Рапопорт,Е.А. Безруков,Roman Sukhanov,Г Е Крупинов
出处
期刊:Andrologiâ i Genitalʹnaâ Hirurgiâ [ABV-press]
卷期号:19 (1): 59-62
标识
DOI:10.17650/2070-9781-2018-19-1-59-62
摘要

Introduction. In recent years, due to the progressive increase in the prevalence of castration-resistant prostate cancer (CRPC), the question of the sequence of prescription drugs is becoming more acute. Objective is to compare the effectiveness of various regimens of treatment of CRPC with the use of abirateron acetate and docetaxel. Materials and methods. The analysis included 83 patients with CRPC, which were divided into 2 groups depending on the sequence of appointment of abiraterone acetate and docetaxel. Results. Differences in the level of 2-year survival were statistically insignificant (73,2 % in the 1st group, 69 % in the 2nd group), and 3-year survival significantly differed: in the 1st group – 29,3 %, in the 2nd group – 16,7 % (p <0.05). Due to the short duration of the analysis, 5-year survival was not evaluated. The average value of overall survival in the appointment of the first docetaxel, then abiraterone acetate was 32 months, with the reverse regimen (abiraterone acetate, then docetaxel) – 27 months (p = 0.01). Conclusion . The scheme with the appointment of the first docetaxel, then abiraterone acetate is more effective from the point of view of affect on overall and 3-year survival in patients with CRPC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
柒柒钓叟莲娃完成签到,获得积分10
刚刚
易福林完成签到,获得积分10
刚刚
无花果的应助被Czz采纳,获得10
1秒前
vbmc发布了新的文献求助10
1秒前
2秒前
3秒前
3秒前
Nole的应助被普鲁卡因采纳,获得10
4秒前
科研怪兽发布了新的文献求助20
4秒前
小蘑菇的应助被普通人阿影采纳,获得10
4秒前
5秒前
CC完成签到,获得积分10
5秒前
5秒前
数漫完成签到 ,获得积分10
5秒前
零负一的应助被Emilia采纳,获得60
6秒前
6秒前
zikw完成签到 ,获得积分10
6秒前
易福林发布了新的文献求助10
7秒前
可靠碧萱发布了新的文献求助10
8秒前
Youdge的应助被阮婷采纳,获得10
9秒前
Osborn完成签到,获得积分10
10秒前
刘云飞发布了新的文献求助10
11秒前
11秒前
单薄开山完成签到,获得积分10
11秒前
wuwu发布了新的文献求助10
11秒前
郑睿涛发布了新的文献求助10
12秒前
12秒前
盒子发布了新的文献求助10
13秒前
孟先生的小混蛋完成签到,获得积分10
13秒前
Li完成签到,获得积分10
13秒前
CodeCraft的应助被笑嘻嘻采纳,获得10
14秒前
Hello的应助被core采纳,获得10
14秒前
14秒前
Jasper的应助被111采纳,获得10
14秒前
GGB发布了新的文献求助10
14秒前
15秒前
16秒前
科研通AI2S的应助被Eric采纳,获得10
16秒前
华仔的应助被周周周采纳,获得10
17秒前
小耶发布了新的文献求助10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183792
求助须知:如何正确求助?哪些是违规求助? 9573020
关于积分的说明 21828776
捐赠科研通 7780959
什么是DOI,文献DOI怎么找? 3434116
关于科研通互助平台的介绍 2558301
邀请新用户注册赠送积分活动 2480611